Mather Group, Llc. Moderna, Inc. Transaction History

Mather Group, Llc.

$8.17 Billion
Q2 2024

A detailed history of Mather Group, Llc. transactions in Moderna, Inc. stock. As of the latest transaction made, Mather Group, Llc. holds 1,019 shares of MRNA stock, worth $66,999. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,019

Previous 576 76.91%

Holding current value

$66,999

Previous $61,000 98.36%

% of portfolio

0.0%

Previous 0.0%

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 08, 2024	BUY	$101.21 - $166.61 $44,836 - $73,808	443 Added 76.91%	1,019 $121,000
Q1 2024 Apr 08, 2024	BUY	$85.37 - $115.44 $49,173 - $66,493	576 New	576 $61,000
Q4 2022 Mar 10, 2023	SELL	$118.38 - $210.04 $71,146 - $126,234	-601 Reduced 8.35%	6,599 $1.19 Million
Q3 2022 Nov 14, 2022	SELL	$118.07 - $194.18 $62,695 - $103,109	-531 Reduced 6.87%	7,200 $851,000
Q2 2022 Aug 16, 2022	BUY	$117.13 - $176.59 $215,050 - $324,219	1,836 Added 31.15%	7,731 $1.1 Million
Q1 2022 May 13, 2022	BUY	$126.46 - $235.05 $745,481 - $1.39 Million	5,895 New	5,895 $1.02 Million

Others Institutions Holding MRNA

# of Institutions

1,113

Shares Held

241M

Call Options Held

9.26M

Put Options Held

12.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mather Group, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Mather Group, Llc. with notifications on news.

Account